IBIO
iBio, Inc. · NASDAQ · Healthcare · USD · 10-K for 2026, filed 2026-08-28
Figures on this page computed 2026-11-08 12:41 UTC
Last close
0.80USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2026, filed 2026-08-28
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0001420720-26-000020
- Reported in
- USD
- computed
- 10-K for 2026, filed 2026-08-28
-111.5%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0001420720-26-000020
- Reported in
- USD
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
-33044.0%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0001420720-26-000020
- Reported in
- USD
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
-23796.0%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0001420720-26-000020
- Reported in
- USD
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
0.03Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2026
- Accession
- 0001420720-26-000020
- Reported in
- USD
- 10-K for 2026, filed 2026-08-28
- 10-K for 2026, filed 2026-08-28
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Growth is the furthest below its sector's middle: 0.10 against 0.50 on the market's range.
- Growth-46.9%10 of 100, below its sector
- Returns on capital-111.5%14 of 100, below its sector
- Margins-35141.0%0 of 100, below its sector
- Price0.9x37 of 100, below its sector
- Safety0.0365 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
5 of 5 readExcept where said otherwise: 10-K for 2026, filed 2026-08-28
- Sales0.11x
Its own average over 10 years, 947.4K.
- Profit1.18x
Its own average over 10 years, -28.0M.
- Free cash flow1.03x
Its own average over 10 years, -23.2M.
- Debt0.15x
Its own average over 5 years, 15.1M.
- Price0.00x
Its own average over 11 years, 492. Market data, 2026-11-04
Price is furthest from its own average, at 0.00 times.
Sales is 0.11 times its own 10-year average; Profit is 1.18 times its own 10-year average; Free cash flow is 1.03 times its own 10-year average; Debt is 0.15 times its own 5-year average; Price is 0.00 times its own 11-year average.
Every figure in this lens
Except where said otherwise: 10-K for 2026, filed 2026-08-28
Sales against its own 10-year average0.11
- Source
- filed
- Statement
- income
- Fiscal year
- 2026
- Accession
- 0001420720-26-000020
- Reported in
- USD
Profit against its own 10-year average1.18
- Source
- filed
- Statement
- income
- Fiscal year
- 2026
- Accession
- 0001420720-26-000020
- Reported in
- USD
Free cash flow against its own 10-year average1.03
- Source
- filed
- Statement
- income
- Fiscal year
- 2026
- Accession
- 0001420720-26-000020
- Reported in
- USD
Debt against its own 5-year average0.15
- Source
- filed
- Statement
- income
- Fiscal year
- 2026
- Accession
- 0001420720-26-000020
- Reported in
- USD
Price against its own 11-year average0.002Market data, 2026-11-04
- Source
- market
- Taken on
- 2026-11-04
- Reported in
- USD